Skip to main content
Erschienen in: Psychiatric Quarterly 3/2021

25.11.2020 | Original Paper

The Power of Perception: Lived Experiences with Diagnostic Labeling in Mental Health Recovery without Ongoing Medication Use

verfasst von: Ray Eads, Mo Yee Lee, Chang Liu, Nancy Yates

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

The recovery movement in mental health emphasizes holistic and individualized treatment through many pathways to recovery, though the majority of mental health treatment and existing literature emphasize pharmacotherapy and medication adherence for major mental health conditions. The reimbursement system and research literature are oriented around formal diagnostic categories based in a biomedical perspective of mental health problems, but diagnostic labels also carry stigma and influence how clients perceive themselves and their mental health problems. To investigate the influence of labeling and perception in alternate pathways to recovery, this qualitative study explores the lived experience of diagnostic labeling and self-perception among persons in sustained recovery without ongoing medication use. The study used a grounded theory approach to analyze data from in-depth interviews with 19 participants. Participants had previously received diagnoses of schizophrenia, bipolar disorder, and/or major depression, met criteria for functional recovery, and were no longer taking psychotropic medications for 12 months. The participants identified positive perceptions—externalization of the problem and hope for an external “cure”—and negative perceptions—stigma and powerlessness—following a diagnostic label. Notably, the theme of powerlessness related to the initially positive themes as the diagnosis placed the problem outside their control and some participants experienced treatments as unhelpful. Participants succeeded in overcoming powerlessness by finding internalized solutions and redefining their mental health experience as transformative. Rather than pressing clients to accept their diagnosis or “illness,” mental health providers can support multiple pathways to recovery by emphasizing empowerment and personal meaning-making in the recovery process.
Literatur
1.
Zurück zum Zitat Carpenter J. Mental health recovery paradigm: implications for social work. Health Soc Work. 2002;27:86–94.CrossRefPubMed Carpenter J. Mental health recovery paradigm: implications for social work. Health Soc Work. 2002;27:86–94.CrossRefPubMed
6.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
7.
Zurück zum Zitat Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314:1818–31.CrossRefPubMedPubMedCentral Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314:1818–31.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ciprani A, Reid K, Young AH, Macritchie K, Geddes J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 2013;2013:CD003196. Ciprani A, Reid K, Young AH, Macritchie K, Geddes J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 2013;2013:CD003196.
9.
Zurück zum Zitat Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression (review). Cochrane Database Syst Rev. 2004;2004:CD003012.PubMedCentral Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression (review). Cochrane Database Syst Rev. 2004;2004:CD003012.PubMedCentral
10.
Zurück zum Zitat Ortiz-Orendain J, Castiello-De Obeso S, Colunga-Lozano LE, Hu Y, Maayan N, Adams CE. Antipsychotic combinations for schizophrenia. Cochrane Database Syst Rev. 2017;2017:CD009005.PubMedCentral Ortiz-Orendain J, Castiello-De Obeso S, Colunga-Lozano LE, Hu Y, Maayan N, Adams CE. Antipsychotic combinations for schizophrenia. Cochrane Database Syst Rev. 2017;2017:CD009005.PubMedCentral
11.
Zurück zum Zitat Ben-Zeev D, Young MA, Corrigan PW. DSM-V and the stigma of mental illness. J Ment Health. 2010;19:318–27.CrossRefPubMed Ben-Zeev D, Young MA, Corrigan PW. DSM-V and the stigma of mental illness. J Ment Health. 2010;19:318–27.CrossRefPubMed
12.
Zurück zum Zitat Corrigan PW. How clinical diagnosis might exacerbate the stigma of mental illness. Soc Work. 2007;52:31–9.CrossRefPubMed Corrigan PW. How clinical diagnosis might exacerbate the stigma of mental illness. Soc Work. 2007;52:31–9.CrossRefPubMed
13.
15.
Zurück zum Zitat Soundy A, Stubbs B, Roskell C, Williams SE, Fox A, Vancampfort D. Identifying the facilitators and processes which influence recovery in individuals with schizophrenia: a systematic review and thematic synthesis. J Ment Health. 2015;24:103–10.CrossRefPubMed Soundy A, Stubbs B, Roskell C, Williams SE, Fox A, Vancampfort D. Identifying the facilitators and processes which influence recovery in individuals with schizophrenia: a systematic review and thematic synthesis. J Ment Health. 2015;24:103–10.CrossRefPubMed
17.
Zurück zum Zitat Rose D, Thornicroft G, Pinfold V, Kassam A. 250 labels used to stigmatise people with mental illness. BMC Health Serv Res. 2007;7:1–7.CrossRef Rose D, Thornicroft G, Pinfold V, Kassam A. 250 labels used to stigmatise people with mental illness. BMC Health Serv Res. 2007;7:1–7.CrossRef
19.
Zurück zum Zitat Lebowitz MS, Ahn WK. Effects of biological explanations for mental disorders on clinicians’ empathy. Proc Natl Acad Sci U S A. 2014;111:17786–90.CrossRefPubMedPubMedCentral Lebowitz MS, Ahn WK. Effects of biological explanations for mental disorders on clinicians’ empathy. Proc Natl Acad Sci U S A. 2014;111:17786–90.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Lebowitz MS, Ahn WK, Oltman K. Sometimes more competent, but always less warm: perceptions of biologically oriented mental-health clinicians. Int J Soc Psychiatry. 2015;61:668–76.CrossRefPubMed Lebowitz MS, Ahn WK, Oltman K. Sometimes more competent, but always less warm: perceptions of biologically oriented mental-health clinicians. Int J Soc Psychiatry. 2015;61:668–76.CrossRefPubMed
21.
22.
Zurück zum Zitat Tekin Ş. Self-concept through the diagnostic looking glass: narratives and mental disorder. Philos Psychol. 2011;24:357–80.CrossRef Tekin Ş. Self-concept through the diagnostic looking glass: narratives and mental disorder. Philos Psychol. 2011;24:357–80.CrossRef
23.
Zurück zum Zitat Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry. 2011;199:445–52.CrossRefPubMed Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry. 2011;199:445–52.CrossRefPubMed
24.
Zurück zum Zitat Brown JVE, Walton N, Meader N, Todd A, Webster LAD, Steele R, et al. Pharmacy-based management for depression in adults. Cochrane Database Syst Rev. 2019;2019:CD013299.PubMedCentral Brown JVE, Walton N, Meader N, Todd A, Webster LAD, Steele R, et al. Pharmacy-based management for depression in adults. Cochrane Database Syst Rev. 2019;2019:CD013299.PubMedCentral
25.
Zurück zum Zitat Werremeyer A, Skoy E, Aalgaard KG. Use of Photovoice to understand the experience of taking psychotropic medications. Qual Health Res. 2017;27:1959–69.CrossRefPubMed Werremeyer A, Skoy E, Aalgaard KG. Use of Photovoice to understand the experience of taking psychotropic medications. Qual Health Res. 2017;27:1959–69.CrossRefPubMed
26.
Zurück zum Zitat De las Cuevas C, Peñate W. Explaining pharmacophobia and pharmacophilia in psychiatric patients: Relationship with treatment adherence. Hum Psychopharmacol Clin Exp. 2015;30:377–83.CrossRef De las Cuevas C, Peñate W. Explaining pharmacophobia and pharmacophilia in psychiatric patients: Relationship with treatment adherence. Hum Psychopharmacol Clin Exp. 2015;30:377–83.CrossRef
27.
Zurück zum Zitat Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with severe mental illness, II: long-term outcomes of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry. 1987;144:727–35.CrossRefPubMed Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with severe mental illness, II: long-term outcomes of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry. 1987;144:727–35.CrossRefPubMed
28.
Zurück zum Zitat Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry. 2002;14:256–72.CrossRef Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry. 2002;14:256–72.CrossRef
29.
Zurück zum Zitat Rosen CS, Drescher KD, Moos RH, Finney JW, Murphy RT, Gusman F. Six and ten item indices of psychological distress: based on the symptom Checklist-90. Assessment. 2000;7:103–11.CrossRefPubMed Rosen CS, Drescher KD, Moos RH, Finney JW, Murphy RT, Gusman F. Six and ten item indices of psychological distress: based on the symptom Checklist-90. Assessment. 2000;7:103–11.CrossRefPubMed
30.
Zurück zum Zitat Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale—Prelimimary report. Psychopharmacol Bull. 1973;9:13–28.PubMed Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale—Prelimimary report. Psychopharmacol Bull. 1973;9:13–28.PubMed
31.
Zurück zum Zitat Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks: Sage; 2008.CrossRef Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks: Sage; 2008.CrossRef
32.
Zurück zum Zitat Glaser BG. Theoretical sensitivity: advances in the methodology of grounded theory. Mill Valley: Sociology Press; 1978. Glaser BG. Theoretical sensitivity: advances in the methodology of grounded theory. Mill Valley: Sociology Press; 1978.
33.
Zurück zum Zitat Lincoln YS, Guba EG. Naturalistic inquiry. In: Naturalistic inquiry. Newbury Park: Sage; 1985.CrossRef Lincoln YS, Guba EG. Naturalistic inquiry. In: Naturalistic inquiry. Newbury Park: Sage; 1985.CrossRef
34.
Zurück zum Zitat Padgett DK. Qualitative methods in social work research. 2nd ed. Thousand Oaks: Sage; 2008. Padgett DK. Qualitative methods in social work research. 2nd ed. Thousand Oaks: Sage; 2008.
Metadaten
Titel
The Power of Perception: Lived Experiences with Diagnostic Labeling in Mental Health Recovery without Ongoing Medication Use
verfasst von
Ray Eads
Mo Yee Lee
Chang Liu
Nancy Yates
Publikationsdatum
25.11.2020
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 3/2021
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-020-09866-8

Weitere Artikel der Ausgabe 3/2021

Psychiatric Quarterly 3/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.